PHARMACOLOGICAL ACTIVATION OF THE p53 PATHWAY BY NUTLIN-3 EXERTS ANTI-TUMORAL EFFECTS IN MEDULLOBLASTOMAS

被引：0
|
作者：
Kuenkele, Annette [1 ]
De Preter, Katleen [2 ]
Heukamp, Lukas [3 ]
Thor, Theresa [1 ]
Pajtler, Kristian [1 ]
Hartmann, Wolfgang [3 ]
Mittelbronn, Michel [4 ]
Grotzer, Michael [5 ]
Deubzer, Hedwig [6 ]
Speleman, Frank [2 ]
Schramm, Alexander [1 ]
Eggert, Angelika [1 ]
Schulte, Johannes [1 ]
机构：
[1] Univ Childrens Hosp Essen, Essen, Germany
[2] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium
[3] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[4] Goethe Univ Frankfurt, Inst Neurol, Frankfurt, Germany
[5] Childrens Hosp Zurich, Zurich, Switzerland
[6] German Canc Res Ctr, D-6900 Heidelberg, Germany
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [21] Pharmacological activation of the p53 pathway in haematological malignancies
    Saha, Manujendra N.
    Micallef, Johann
    Qiu, Lugui
    Chang, Hong
    JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (03) : 204 - 209
  • [22] The MDM2 Inhibitor Nutlin-3 But Not the p53 Activator RITA Induces Loss-of-function p53 Mutations
    Michaelis, M.
    Rothweiler, F.
    Barth, S.
    Cinatl, J.
    van Rikxoort, M.
    von Deimling, A.
    Roedel, F.
    Speidel, D.
    Cinatl, J., Jr.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 43 - 43
  • [23] Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a
    Brennan, Rachel C.
    Federico, Sara
    Bradley, Cori
    Zhang, Jiakun
    Flores-Otero, Jacqueline
    Wilson, Matthew
    Stewart, Clinton
    Zhu, Fangyi
    Guy, Kip
    Dyer, Michael A.
    CANCER RESEARCH, 2011, 71 (12) : 4205 - 4213
  • [24] p53 mutations induced by the MDM2 inhibitor nutlin-3 in p53 wild-type neuroblastoma cells
    Michaelis, M.
    Wass, M.
    Cinatl, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S72 - S72
  • [25] Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53
    C F Cheok
    N Kua
    P Kaldis
    D P Lane
    Cell Death & Differentiation, 2010, 17 : 1486 - 1500
  • [26] Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia
    E McCormack
    I Haaland
    G Venås
    R B Forthun
    S Huseby
    G Gausdal
    S Knappskog
    D R Micklem
    J B Lorens
    Ø Bruserud
    B T Gjertsen
    Leukemia, 2012, 26 : 910 - 917
  • [27] Nutlin-3: A novel potential therapeutic in p53 wild-type ovarian carcinomas.
    King, Erin Rebecca
    Mullany, Lisa K.
    Richards, JoAnne S.
    Gershenson, David Marc
    Wong, Kwong-Kwok
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53
    Cheok, C. F.
    Kua, N.
    Kaldis, P.
    Lane, D. P.
    CELL DEATH AND DIFFERENTIATION, 2010, 17 (09): : 1486 - 1500
  • [29] Functional Analysis of the p53 Pathway in Neuroblastoma Cells Using the Small-Molecule MDM2 Antagonist Nutlin-3
    Van Maerken, Tom
    Rihani, Ali
    Dreidax, Daniel
    De Clercq, Sarah
    Yigit, Nurten
    Marine, Jean-Christophe
    Westermann, Frank
    De Paepe, Anne
    Vandesompele, Jo
    Speleman, Frank
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (06) : 983 - 993
  • [30] Anti-tumoral Effects of miR-3189-3p in Glioblastoma
    Jeansonne, Duane
    DeLuca, Mariacristina
    Marrero, Luis
    Lassak, Adam
    Pacifici, Marco
    Wyczechowska, Dorota
    Wilk, Anna
    Reiss, Krzysztof
    Peruzzi, Francesca
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (13) : 8067 - 8080
12345